Gene · 27165
Papers2,122
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,122
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Structure, Biosynthesis, and Function of β-1,6-Glucan in the Fungal Cell Wall. | Biomolecules | 2026 | 42793065 | PubTator, text mining | PubMed |
| High-Throughput Characterization of Human Fibroblast Responses to a Panel of Staphylococcus aureus Antigen Proteins Using Olink Proteomics. | Open Forum Infect Dis | 2026 | 42751267 | PubTator, text mining | PubMed |
| miR-15a-5p Regulates Ferroptosis in Glioblastoma by Targeting GLS2. | CNS Neurosci Ther | 2026 | 42669141 | PubTator, text mining | PubMed |
| Resveratrol Alleviates Chronic Intermittent Hypoxia-Induced Lung Injury by Inhibiting Ferroptosis via SIRT1-Dependent Modulation of the EGR1/GLS2 Axis. | Antioxid Redox Signal | 2026 | 42581022 | PubTator, text mining | PubMed |
| LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. | Cell Death Dis | 2026 | 42476970 | PubTator, text mining | PubMed |
| Oxidative Stress Induced Senescent Macrophage-Driven Squamous Cell Carcinoma Invasion via Glutamine Metabolic Reprogramming. | Aging Cell | 2026 | 42333921 | PubTator, text mining | PubMed |
| B cells just got a workout. | Cell | 2026 | 42208497 | PubTator, text mining | PubMed |
| S-PrediXcan predicted gene expression in human placenta is associated with childhood-onset asthma risk. | Sci Rep | 2026 | 42129325 | PubTator, text mining | PubMed |
| Leveraging mitochondrial dynamics-related risk signatures to predict the prognosis and tumor microenvironment of lung adenocarcinoma. | Discov Oncol | 2026 | 42104168 | PubTator, text mining | PubMed |
| B cell deficiency limits exercise capacity by remodeling liver glutamate metabolism. | Cell | 2026 | 41999743 | PubTator, text mining | PubMed |
| Glioma biomarker analysis and drug targeting prediction based on ferroptosis-related genes. | Medicine (Baltimore) | 2026 | 41961695 | PubTator, text mining | PubMed |
| Targeting Glutaminase Isoforms GLS and GLS2 in Luminal Breast Cancer. | Int J Mol Sci | 2026 | 41898641 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Efficacy and safety of supportive and immunosuppressive therapies in the treatment of lgA nephropathy: a network Meta-analysis of randomized clinical trials. | BMC Nephrol | 2026 | 41840527 | PubTator, text mining | PubMed |
| Sub-national modelling of surveillance sensitivity to inform declaration of disease elimination: A retrospective validation against the elimination of wild poliovirus in Nigeria. | PLoS Comput Biol | 2026 | 41838675 | PubTator, text mining | PubMed |
| Obesity-associated metabolic dysregulation aggravates myocardial ischemia-reperfusion injury through Gls2-mediated ferroptosis. | Eur J Pharmacol | 2026 | 41819522 | PubTator, text mining | PubMed |
| SP1-Induced GLS2 Promotes Hypoxia/Reoxygenation-Induced AC16 Cell Injury by Regulating Ferroptosis Via an AMPK/mTOR Signaling Pathway. | J Biochem Mol Toxicol | 2026 | 41817959 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| MYC-Mediated Functional Manifestation of IDH1 Mutations in Intrahepatic Cholangiocarcinoma Confers Sensitivity to (+)-JQ1. | Int J Biol Sci | 2026 | 41800252 | PubTator, text mining | PubMed |
| Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target. | Mol Biomed | 2026 | 41795043 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27165/papers